Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0H5CE
|
|||
| Former ID |
DNC005021
|
|||
| Drug Name |
4-Pyridin-3-yl-5-quinolin-4-yl-thiazol-2-ylamine
|
|||
| Synonyms |
CHEMBL359724; 4-Pyridin-3-yl-5-quinolin-4-yl-thiazol-2-ylamine; BDBM50151364
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H12N4S
|
|||
| Canonical SMILES |
C1=CC=C2C(=C1)C(=CC=N2)C3=C(N=C(S3)N)C4=CN=CC=C4
|
|||
| InChI |
1S/C17H12N4S/c18-17-21-15(11-4-3-8-19-10-11)16(22-17)13-7-9-20-14-6-2-1-5-12(13)14/h1-10H,(H2,18,21)
|
|||
| InChIKey |
SSOAVUCQSQRZGQ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Identification of 1,5-naphthyridine derivatives as a novel series of potent and selective TGF-beta type I receptor inhibitors. J Med Chem. 2004 Aug 26;47(18):4494-506. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.